This Holiday Season Can Stand as a Turning Point in Our Nation’s Control of the COVID-19 Pandemic

With numbers of infections, illnesses, hospitalizations and deaths caused by COVID-19 at record highs as this holiday season begins, the risks posed by the spread of the coronavirus are more dangerous than at any time since its emergence last December.

Seven Institutions Receive the IDSA Antimicrobial Stewardship Center of Excellence Designation

IDSA awarded seven institutions the designation of Antimicrobial Stewardship Center of Excellence. The designated hospitals have created stewardship programs led by infectious diseases-trained physicians and pharmacists that advance science in antimicrobial resistance.

IDSA Provides Feedback to Strengthen FDA Concept Paper on Ranking Antimicrobial Drugs

Cornelius J. Clancy, M.D., member of the Infectious Diseases Society of America’s Antimicrobial Resistance Committee, presented on behalf of IDSA at today’s Food and Drug Administration public meeting to provide feedback on an FDA concept paper regarding the ranking of antimicrobial drugs according to their importance

Statement on the Emergency Use Authorization of Bamlanivimab

We share and appreciate the urgency in expanding therapeutic options for COVID-19 as daily case counts and hospitalization rates reach record levels. For new therapeutics to be used widely and routinely outside of clinical trials, we urge that there be sufficient safety and efficacy data to be confident regarding their use.

IDSA and HIVMA Congratulate the President-elect, Offer Guidance on Pandemic Response

The Infectious Diseases Society of America and its HIV Medicine Association have reached out today to President-elect Joe Biden to congratulate him and to offer their memberships’ expertise as the new administration takes on the challenges of the COVID-19 pandemic and other infectious diseases threats.

IDSA and HIVMA Release New Comprehensive Primary Care Guidance for People with HIV

New guidance published today by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates the 2013 guideline for providing comprehensive evidence-based primary care to people with HIV.

In Comments to DHS, Medical Societies Say Proposed Visa Rule for Physicians Will Exacerbate Our Disease Response Challenges

The Infectious Diseases Society of America, HIV Medicine Association, Pediatric Diseases Society and the Society of Healthcare Epidemiology of America have called on the Department of Homeland Security to exempt physicians working in the United States on J-1 visas from the agency’s proposed rule

Ignoring the Impacts of Inequities Stymies Science

"In September the Trump Administration released an “Executive Order on Combating Race and Sex Stereotyping,” which would allow federal agencies to terminate contracts intended to help promote study and understanding of diversity, equity and inclusion across government institutions."

OASIS Wins Grand Prize at IDea Incubator Competition Held in Collaboration with Johnson & Johnson Innovation – JLABS

The Infectious Diseases Society of America’s (IDSA) Foundation is thrilled to announce the winners of the IDea Incubator, a pitch-style competition held this year in collaboration with Johnson & Johnson Innovation – JLABS  at the first IDWeek conference held virtually.

Paper Describes Unique Opportunities for ID, HIV Professionals to Inform Improved Public Health Responses

A paper jointly published in Clinical Infectious Diseases and the Journal of Pediatric Infectious Diseases describes how the frontline experiences and perspectives of infectious diseases and HIV health care professionals have made pivotal differences to critical public health responses, from informing domestic and global efforts to prevent and contain pandemics

Order to Reclassify Civil Service Posts Will Compromise Responses to Public Health Threats

The executive order signed last week that strips protections from our nation’s civil service workforce comes at a time when the critical role of career staff in guiding federal responses to public health needs could not be more clear.

Antibiotic Use At Veterans Affairs’ Hospitals Increases During COVID-19 Pandemic, Reversing A Four-Year Downward Trend

New research shows a widespread increase in antibiotic use across Department of Veterans Affairs medical facilities during the initial surge of COVID-19 cases, abruptly reversing steady reductions over the prior four years, according to a new study being presented at IDWeek 2020.